Avalo Therapeutics, Inc. (AVTX) shares outstanding

Shares outstanding · fiscal 2025
13.40M

Avalo Therapeutics, Inc. (AVTX) had 13.40M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 78.8% higher than the 7.50M of fiscal 2024. Figures as of 18 Nov 2026, 11:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
13.40M
Change on fiscal 2024
+78.8%
Growth, 10 years
+165.4% a year
Highest on record
13.40Mfiscal 2025
Lowest on record
773fiscal 2015
Fiscal years on record
82015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Avalo Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 57.82M shares outstanding today.

Over the ten fiscal years to 2025 the diluted share count grew at a compound 165.4% a year. Across the 8 fiscal years on record (2015–2025), the highest was 13.40M in fiscal 2025 and the lowest 773 in fiscal 2015.

History · 8 fiscal years

Shares outstanding by fiscal year

Avalo Therapeutics, Inc. shares outstanding, year by year

Avalo Therapeutics, Inc. (AVTX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202513.40M 78.8% up
20247.50M 2,599.2% up
2023277.73K 608.8% up
202239.18K—
201812.07K 85.4% up
20176.51K 112.4% up
20163.07K 296.7% up
2015773—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on AVTX

Avalo Therapeutics, Inc., figure by figure

Avalo Therapeutics, Inc. (AVTX) overview: price, valuation and scorecard

Avalo Therapeutics, Inc. shares outstanding: questions and answers

How many shares does Avalo Therapeutics, Inc. have?

Avalo Therapeutics, Inc. (AVTX) had 13.40M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 78.8% higher than the 7.50M of fiscal 2024. The market data feed counts 57.82M shares outstanding today.

What is the growth rate of Avalo Therapeutics, Inc.'s diluted share count?

Over the ten fiscal years to 2025 the diluted share count grew at a compound 165.4% a year.

What are the highest and lowest diluted share count figures on record for Avalo Therapeutics, Inc.?

Across the 8 fiscal years on record (2015–2025), the highest was 13.40M in fiscal 2025 and the lowest 773 in fiscal 2015.

How is Avalo Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Avalo Therapeutics, Inc. it is on record here for 8 fiscal years, 2015 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Avalo Therapeutics, Inc. (AVTX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/AVTX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.